

Tired of calling pharmacies to check Relexxii stock? Learn how to use Medfinder, pharmacy apps, and other tools to find availability fast.
If you've ever driven to your pharmacy to pick up Relexxii (methylphenidate hydrochloride extended-release) only to hear "we're out of stock," you're not alone. The broader stimulant shortage that began in late 2022 has affected methylphenidate ER products across the board, and while supply has improved thanks to DEA production quota increases in late 2025, many patients still face unpredictable availability.
The good news: you don't have to call every pharmacy in town to figure out who has it. This guide covers the fastest, most reliable ways to check Relexxii stock — all from your phone or computer.
Medfinder is built specifically for this problem. Instead of calling pharmacies one by one, you can search for Relexxii availability by location and see which pharmacies near you have it in stock — in real time.
Thanks to a partnership between Relexxii's manufacturer and Medfinder, you can use Medfinder's medication locating services completely free of charge.
Here's how it works:
Medfinder is especially useful for controlled substances like Relexxii, where traditional pharmacy stock-checking tools often fall short. It's free to use and doesn't require an account.
Many major pharmacy chains let you check medication availability or manage prescriptions through their apps:
The CVS app shows prescription status and will notify you when your medication is ready. While it doesn't display real-time stock for every drug, you can use the "Transfer a Prescription" feature to check if another CVS location might have Relexxii available. You can also text or chat with a CVS pharmacist directly through the app.
The Walgreens app lets you manage prescriptions and request refills. If your home store is out, you can search nearby Walgreens locations and call or transfer. Walgreens also offers a chat feature within the app.
Walmart's app shows your prescription history and refill status. For controlled substances like Relexxii, you may need to contact the pharmacy directly for stock status, but the app can help you identify nearby locations.
Smaller independent pharmacies may not have apps, but many are surprisingly well-stocked because they have more flexibility in ordering from different wholesalers. A quick call — or better yet, a Medfinder search — can reveal hidden inventory that chain pharmacies don't have.
GoodRx is primarily known as a coupon and price-comparison tool, but it can also help you find pharmacies that carry Relexxii or its generic equivalent, methylphenidate ER. When you search for a medication on GoodRx, it shows prices at nearby pharmacies — and if a pharmacy lists a price, it's a strong signal they carry that medication.
Keep in mind that GoodRx prices reflect coupon-discounted cash prices, which can be useful if you're paying out of pocket. Generic methylphenidate ER can cost as little as $32-$45/month with GoodRx coupons, compared to $350-$505/month for brand-name Relexxii at retail.
For more ways to save, check out our guide: How to Save Money on Relexxii.
Your prescriber's office may have insights into which local pharmacies tend to have Relexxii in stock. Some practices maintain informal lists of pharmacies with reliable stimulant supply, especially during shortage periods. When your doctor writes the prescription, ask: "Do you know which pharmacies near here typically have this in stock?"
Many electronic prescribing systems also allow your doctor to send the prescription directly to a specific pharmacy, so if you've already identified one with stock via Medfinder or another tool, let your doctor know before they submit it.
If you've searched everywhere and Relexxii is truly out of stock in your area, here are your options:
Relexxii comes in seven strengths: 18 mg, 27 mg, 36 mg, 45 mg, 54 mg, 63 mg, and 72 mg. Sometimes a pharmacy may be out of one strength but have another. Your doctor may be able to adjust your regimen — for example, using two lower-strength tablets to achieve the same total dose.
If brand-name Relexxii is unavailable, generic methylphenidate ER (osmotic delivery) may be in stock. The generic is therapeutically equivalent and typically much more affordable. Talk to your doctor and pharmacist about substitution.
If chain pharmacies are out, try:
If the shortage is ongoing and you can't reliably get Relexxii, your doctor may recommend trying a different ADHD medication. Options include other methylphenidate formulations like Aptensio XR or Jornay PM, or amphetamine-based alternatives like Vyvanse. Read more about how Relexxii compares in our guide: How Does Relexxii Work?
Once you find a pharmacy that has Relexxii, these strategies can help you avoid running into the same problem next month:
Because Relexxii is a Schedule II controlled substance, there are some rules that affect how you fill it:
Finding Relexxii in stock shouldn't be a monthly scavenger hunt. Tools like Medfinder take the guesswork out of pharmacy availability, and combining them with pharmacy apps, GoodRx, and a good relationship with your pharmacist can keep your treatment on track — even during shortage periods.
The manufacturer of Relexxii has partnered with Medfinder to provide medication locating services free of charge. Visit medfinder.com to find Relexxii in stock near you at no cost.
New to Relexxii? Start with our overview: What Is Relexxii? Uses, Dosage, and What You Need to Know in 2026. Already taking it and wondering about side effects? Read: Relexxii Side Effects: What to Expect and When to Call Your Doctor.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.